Browse by UCL people
Group by: Type | Date
Number of items: 42.
Article
Amuge, Pauline;
Lugemwa, Abbas;
Wynne, Ben;
Mujuru, Hilda A;
Violari, Avy;
Kityo, Cissy M;
Archary, Moherndran;
... ODYSSEY Trial Team; + view all
(2022)
Once-daily dolutegravir-based antiretroviral therapy in infants and children living with HIV from age 4 weeks: results from the below 14 kg cohort in the randomised ODYSSEY trial.
The Lancet HIV
, 9
(9)
e638-e648.
10.1016/S2352-3018(22)00163-1.
|
|
Bollen, PDJ;
Moore, CL;
Mujuru, HA;
Makumbi, S;
Kekitiinwa, AR;
Kaudha, E;
Parker, A;
... ODYSSEY trial team, .; + view all
(2020)
Simplified dolutegravir dosing for children with HIV weighing 20 kg or more: pharmacokinetic and safety substudies of the multicentre, randomised ODYSSEY trial.
The Lancet HIV
, 7
(8)
e533-e544.
10.1016/S2352-3018(20)30189-2.
|
 |
|
Butler, K;
Inshaw, J;
Ford, D;
Bernays, S;
Scott, K;
Kenny, J;
Klein, N;
... Gibb, D; + view all
(2016)
BREATHER (PENTA 16) short-cycle therapy (SCT) (5 days on/2 days off) in young people with chronic human immunodeficiency virus infection: an open, randomised, parallel-group Phase II/III trial.
Health Technology Assessment
, 20
(49)
10.3310/hta20490.
|
|
Butler, K;
Turkova, A;
Inshaw, J;
Compagnucci, A;
Kenny, J;
Saidi, Y;
Musiime, V;
... Gibb, DM; + view all
(2016)
Weekends-off efavirenz-based antiretroviral therapy in HIV-infected children, adolescents, and young adults (BREATHER): a randomised, open-label, non-inferiority, phase 2/3 trial.
LANCET HIV
, 3
(9)
E421-E430.
10.1016/S2352-3018(16)30054-6.
|
|
Cambiano, V;
Ford, D;
Mabugu, T;
Napierala Mavedzenge, S;
Miners, A;
Mugurungi, O;
Nakagawa, F;
... Phillips, A; + view all
(2015)
Assessment of the Potential Impact and Cost-effectiveness of Self-Testing for HIV in Low-Income Countries.
Journal of Infectious Diseases
, 212
(4)
pp. 570-577.
10.1093/infdis/jiv040.
|
 |
|
Cataldo, F;
Seeley, J;
Nkhata, MJ;
Mupambireyi, Z;
Tumwesige, E;
Gibb, DM;
Lablite Team;
(2018)
She knows that she will not come back: tracing patients and new thresholds of collective surveillance in PMTCT Option B+.
BMC Health Services Research
, 18
, Article 76. 10.1186/s12913-017-2826-7.
|
|
|
Chan, AK;
Ford, D;
Namata, H;
Muzambi, M;
Nkhata, MJ;
Abongomera, G;
Mambule, I;
... Lablite Team, ; + view all
(2014)
The Lablite project: A cross-sectional mapping survey of decentralized HIV service provision in Malawi, Uganda and Zimbabwe.
BMC Health Services Research
, 14
, Article 352. 10.1186/1472-6963-14-352.
|
|
|
Chappell, Elizabeth;
Chimwaza, Anesu;
Manika, Ngoni;
Wedderburn, Catherine;
Mupambireyi Nenguke, Zivai;
Calder, Hannah;
Cowan, Frances;
... Bwakura-Dangarembizi, Mutsa; + view all
(2022)
Impact of the COVID-19 pandemic on the provision and uptake of services for the prevention of mother-to-child transmission of HIV in Zimbabwe.
PLOS Global Public Health
, 3
(8)
, Article e0002296. 10.1371/journal.pgph.0002296.
|
|
|
Chiwaula, LS;
Revill, P;
Ford, D;
Nkhata, M;
Mabugu, T;
Hakim, J;
Kityo, C;
... van den Berg, B; + view all
(2016)
Measuring and Valuing Informal Care for Economic Evaluation of HIV/AIDS Interventions: Methods and Application in Malawi.
Value in Health Regional Issues
, 10
pp. 73-78.
10.1016/j.vhri.2016.08.002.
|
|
Crook, AM;
Ford, D;
Gafos, M;
Hayes, R;
Kamali, A;
Kapiga, S;
Nunn, A;
... McCormack, S; + view all
(2014)
Injectable and oral contraceptives and risk of HIV acquisition in women: an analysis of data from the MDP301 trial.
Hum Reprod
, 29
(8)
pp. 1810-1817.
10.1093/humrep/deu113.
|
|
|
Ewings, FM;
Ford, D;
Walker, AS;
Carpenter, J;
Copas, A;
(2014)
Optimal CD4 count for treatment initiation in HIV-infection: impact of CD4 observation frequency and grace periods, and performance of dynamic marginal structural models, in realistic scenarios.
Epidemiology
, 25
(2)
pp. 194-202.
10.1097/EDE.0000000000000043.
|
|
|
Farmer, R;
Daniel, R;
Ford, D;
Cook, A;
Musiime, V;
Bwakura-Dangarembizi, M;
Gibb, D;
... Walker, A; + view all
(2020)
Marginal Structural Models for repeated measures where intercept and slope are correlated: An application exploring the benefit of nutritional supplements on weight gain in HIV-infected children initiating antiretroviral therapy.
PLoS One
, 15
(7)
, Article e0233877. 10.1371/journal.pone.0233877.
|
|
|
Farmer, RE;
Ford, D;
Forbes, HJ;
Chaturvedi, N;
Kaplan, R;
Smeeth, L;
Bhaskaran, K;
(2017)
Metformin and cancer in type 2 diabetes: a systematic review and comprehensive bias evaluation.
[Corrigendum].
International Journal of Epidemiology
, 46
(2)
, Article 745. 10.1093/ije/dyx046.
|
|
|
Farmer, RE;
Ford, D;
Forbes, HJ;
Chaturvedi, N;
Kaplan, R;
Smeeth, L;
Bhaskaran, K;
(2017)
Metformin and cancer in type 2 diabetes: a systematic review and comprehensive bias evaluation.
International Journal of Epidemiology
, 46
(2)
pp. 728-744.
10.1093/ije/dyw275.
|
|
Farmer, RE;
Ford, D;
Mathur, R;
Chaturvedi, N;
Kaplan, R;
Smeeth, L;
Bhaskaran, K;
(2019)
Metformin use and risk of cancer in patients with type 2 diabetes: a cohort study of primary care records using inverse probability weighting of marginal structural models.
International Journal of Epidemiology
10.1093/ije/dyz005.
(In press).
|
|
|
Farmer, RE;
Kounali, D;
Walker, AS;
Savovic, J;
Richards, A;
May, MT;
Ford, D;
(2018)
Application of causal inference methods in the analyses of randomised controlled trials: a systematic review.
Trials
, 19
, Article 23. 10.1186/s13063-017-2381-x.
|
|
|
Ford, D;
Muzambi, M;
Nkhata, MJ;
Abongomera, A;
Joseph, S;
Ndlovu, M;
Mabugu, T;
... Lablite Team, .; + view all
(2017)
Implementation of antiretroviral therapy for life in pregnant/breastfeeding HIV+ women (Option B+) alongside rollout and changing guidelines for ART initiation in rural Zimbabwe: the Lablite Project experience.
JAIDS: Journal of Acquired Immune Deficiency Syndromes
, 74
(5)
pp. 508-516.
10.1097/QAI.0000000000001267.
|
|
Ford, D;
Turner, R;
Turkova, A;
Penazzato, M;
Musiime, V;
Bwakura-Dangarembizi, M;
Violari, A;
... Gibb, DM; + view all
(2018)
Optimizing Clinical Trial Design to Maximize Evidence Generation in Pediatric HIV.
Journal of Acquired Immune Deficiency Syndromes
, 78
(Sup)
S40-S48.
10.1097/QAI.0000000000001748.
|
|
|
Ford, DJ;
Robins, J;
Petersen, M;
Gibb, DM;
Gilks, CF;
Mugyenyi, P;
Grosskurth, H;
... Walker, AS; + view all
(2015)
The impact of different CD4 monitoring and switching strategies on mortality in HIV-infected African adults on antiretroviral therapy; an application of dynamic marginal structural models.
American Journal of Epidemiology
, 182
(7)
10.1093/aje/kwv083.
|
|
Freguja, R;
Bamford, A;
Zanchetta, M;
Del Bianco, P;
Giaquinto, C;
Harper, L;
Dalzini, A;
... De Rossi, A; + view all
(2021)
Long‐term clinical, virological and immunological outcomes following planned treatment interruption in HIV‐infected children.
HIV Medicine
, 22
(3)
pp. 172-184.
10.1111/hiv.12986.
|
|
Gibb, DM;
Ford, D;
(2017)
Impact of decentralization of Antiretroviral Therapy services on HIV testing and care at population level in Agago District in rural Northern Uganda: Results from the Lablite population surveys.
International Health
, 9
(2)
pp. 91-99.
10.1093/inthealth/ihx006.
|
|
Gibb, DM;
Ford, D;
Seeley, J;
Hakim, J;
Gilks, C;
Kityoa, C;
Chan, A;
... Abongomera, G; + view all
(2018)
Patient level benefits associated with decentralisation of antiretroviral therapy services to primary health facilities in Malawi and Uganda.
International Health
, 10
(1)
pp. 8-19.
10.1093/inthealth/ihx061.
|
|
|
Judd, A;
Collins, IJ;
Parrott, F;
Hill, T;
Jose, S;
Ford, D;
Asad, H;
... Sabin, C; + view all
(2017)
Growing up with perinatal HIV: changes in clinical outcomes before and after transfer to adult care in the UK.
J Int AIDS Soc
, 20
(Suppl.3)
, Article 21577. 10.7448/IAS.20.4.21577.
|
|
|
Katongole, F;
Arumugam, T;
Jennings, A;
Mutata, C;
Ssebunya, P;
Wamboi, C;
Green, A;
... Kabasingo, R; + view all
(2025)
BREATHER Plus clinical trial design: A randomised non-inferiority trial evaluating the efficacy, safety and acceptability of short cycle (five days on, two days off) dolutegravir/tenofovir-based triple antiretroviral therapy (ART) compared to daily ART in virologically suppressed adolescents living with HIV aged 12 to <20 years in sub-Saharan Africa.
Contemporary Clinical Trials
, 155
, Article 107963. 10.1016/j.cct.2025.107963.
(In press).
|
|
|
Kiwuwa-Muyingo, S;
Abongomera, G;
Mambule, I;
Senjovu, D;
Katabira, E;
Kityo, C;
Gibb, DM;
... Seeley, J; + view all
(2019)
Lessons for test and treat in an antiretroviral programme after decentralisation in Uganda: a retrospective analysis of outcomes in public healthcare facilities within the Lablite project.
International Health
, 12
(5)
pp. 429-443.
10.1093/inthealth/ihz090.
|
|
|
Le Prevost, M;
Arenas-Pinto, A;
Melvin, D;
Parrott, F;
Foster, C;
Ford, D;
Evangeli, M;
... AALPHI Steering Committee, .; + view all
(2018)
Anxiety and depression symptoms in young people with perinatally acquired HIV and HIV affected young people in England.
AIDS Care
, 30
(8)
pp. 1040-1049.
10.1080/09540121.2018.1441972.
|
|
|
Moore, C;
Turkova, A;
Mujuru, H;
Kekitiinwa, A;
Lugemwa, A;
Kityo, C;
Barlow-Mosha, L;
... ODYSSEY Trial Team; + view all
(2021)
ODYSSEY clinical trial design: a randomised global study to evaluate the efficacy and safety of dolutegravir-based antiretroviral therapy in HIV-positive children, with nested pharmacokinetic sub-studies to evaluate pragmatic WHO-weight-band based dolutegravir dosing.
BMC Infectious Diseases
, 21
, Article 5. 10.1186/s12879-020-05672-6.
|
|
|
Nakagawa, F;
van Sighem, A;
Thiebaut, R;
Smith, C;
Ratmann, O;
Cambiano, V;
Albert, J;
... Phillips, A; + view all
(2016)
A Method to Estimate the Size and Characteristics of HIV-positive Populations Using an Individual-based Stochastic Simulation Model.
Epidemiology
, 27
(2)
pp. 247-256.
10.1097/EDE.0000000000000423.
|
|
Nkhata, MJ;
Muzambi, M;
Ford, D;
Chan, AK;
Abongomera, G;
Namata, H;
Mambule, I;
... Lablite team, .; + view all
(2016)
Shifting human resources for health in the context of ART provision: qualitative and quantitative findings from the Lablite baseline study.
BMC Health Services Research
, 16
, Article 660. 10.1186/s12913-016-1891-7.
|
|
Olson, A;
Walker, AS;
Suthar, AB;
Sabin, C;
Bucher, H;
Jarriin, I;
Moreno, S;
... Ford, D; + view all
(2016)
Limiting cumulative HIV viremia copy years by early treatment reduces risk of AIDS and death.
Journal of Acquired Immune Deficiency Syndromes
, 73
(1)
pp. 100-108.
10.1097/QAI.0000000000001029.
|
|
|
Phillips, A;
Cambiano, V;
Nakagawa, F;
Bansi-Matharu, L;
Wilson, D;
Jani, I;
Apollo, T;
... Revill, P; + view all
(2019)
Cost-per-diagnosis as a metric for monitoring cost effectiveness of HIV testing programmes in low income settings in southern Africa: health economic and modelling analysis.
The Journal of the International AIDS Society (JIAS)
, 22
(7)
, Article e25325. 10.1002/jia2.25325.
|
|
|
Phillips, A;
Cambiano, V;
Nakagawa, F;
Magubu, T;
Miners, A;
Ford, D;
Pillay, D;
... Revill, P; + view all
(2014)
Cost-Effectiveness of HIV Drug Resistance Testing to Inform Switching to Second Line Antiretroviral Therapy in Low Income Settings.
PLoS One
, 9
(10)
, Article e109148 . 10.1371/journal.pone.0109148.
|
|
|
Phillips, A;
Shroufi, A;
Vojnov, L;
Cohn, J;
Roberts, T;
Ellman, T;
Bonner, K;
... Revill, P; + view all
(2015)
Sustainable HIV treatment in Africa through viral-load-informed differentiated care.
Nature
, 528
S68-S76.
10.1038/nature16046.
|
|
|
Phillips, AN;
Cambiano, V;
Nakagawa, F;
Bansi-Matharu, L;
Sow, PS;
Ehrenkranz, P;
Ford, D;
... Revill, P; + view all
(2016)
Cost Effectiveness of Potential ART Adherence Monitoring Interventions in Sub-Saharan Africa.
PLOS ONE
, 11
(12)
, Article e0167654. 10.1371/journal.pone.0167654.
|
|
|
Phillips, AN;
Cambiano, V;
Nakagawa, F;
Ford, D;
Apollo, T;
Murungu, J;
Rousseau, C;
... Revill, P; + view all
(2016)
Point-of-Care Viral Load Testing for Sub-Saharan Africa: Informing a Target Product Profile.
Open Forum Infectious Diseases
, 3
(3)
, Article ofw161. 10.1093/ofid/ofw161.
|
|
Phillips, AN;
Cambiano, V;
Nakagawa, F;
Ford, D;
Lundgren, JD;
Roset-Bahmanyar, E;
Roman, F;
(2014)
Potential Future Impact of a Partially Effective HIV Vaccine in a Southern African Setting.
PLoS One
, 9
(9)
, Article e107214 . 10.1371/journal.pone.0107214.
|
|
|
Tierrablanca, LE;
Ochalek, J;
Ford, D;
Babiker, A;
Gibb, D;
Butler, K;
Turkova, A;
... BREATHER (PENTA 16) Trial Group; + view all
(2018)
Economic evaluation of weekends-off antiretroviral therapy for young people in 11 countries.
Medicine
, 97
(5)
, Article e9698. 10.1097/MD.0000000000009698.
|
|
|
Turkova, A;
White, E;
Mujuru, HA;
Kekitiinwa, AR;
Kityo, CM;
Violari, A;
Lugemwa, A;
... ODYSSEY Trial Team; + view all
(2021)
Dolutegravir as First- or Second-Line Treatment for HIV-1 Infection in Children.
The New England Journal of Medicine
, 385
(27)
pp. 2531-2543.
10.1056/NEJMoa2108793.
|
|
Turkova, A;
Moore, CL;
Butler, K;
Compagnucci, A;
Saïdi, Y;
Musiime, V;
Nanduudu, A;
... BREATHER (PENTA 16) Trial Group, .; + view all
(2018)
Weekends-off efavirenz-based antiretroviral therapy in HIV-infected children, adolescents and young adults (BREATHER): Extended follow-up results of a randomised, open-label, non-inferiority trial.
PLoS One
, 13
(4)
, Article e0196239. 10.1371/journal.pone.0196239.
|
|
|
Vickers, MR;
MacLennan, AH;
Lawton, B;
Ford, D;
Martin, J;
Meredith, SK;
DeStavola, BL;
... WISDOM Team; + view all
(2007)
Main morbidities recorded in the women's international study of long duration oestrogen after menopause (WISDOM): a randomised controlled trial of hormone replacement therapy in postmenopausal women.
BRIT MED J
, 335
(7613)
239 - +.
10.1136/bmj.39266.425069.AD.
|
|
|
White, Ian;
Choodari-Oskooei, Babak;
Sydes, Matthew R;
Kahan, Brennan;
McCabe, Leanne;
Turkova, Anna;
Esmail, Hanif;
... Ford, Deborah; + view all
(2022)
Combining factorial and multi-arm multi-stage platform designs to evaluate multiple interventions efficiently.
Clinical Trials
10.1177/17407745221093577.
(In press).
|
Poster
|
Cambiano, V;
Ford, D;
Mabugu, T;
Napierala Mavedzenge, S;
Miners, A;
Mugurungi, O;
Nakagawa, F;
... Phillips, A; + view all
(2014)
Assessment of the Potential Cost-Effectiveness of HIV Self-Testing in Resource Limited Settings.
Presented at: Conference on Retroviruses and Opportunistic Infections, Boston, MA, USA.
|
|
